$160 Million is the total value of CAXTON CORP's 44 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
XL | New | XL FLEET CORP | $7,119,000 | – | 300,000 | +100.0% | 4.44% | – |
RZLT | New | REZOLUTE INC | $5,087,000 | – | 424,243 | +100.0% | 3.17% | – |
AJAX | New | AJAX I | $3,103,000 | – | 250,000 | +100.0% | 1.93% | – |
LUXAU | New | LUX HEALTH TECH ACQUISITIONunit 11/30/2027 | $2,300,000 | – | 200,000 | +100.0% | 1.43% | – |
MRACU | New | MARQUEE RAINE ACQUISITION COunit 12/01/2025 | $1,143,000 | – | 105,500 | +100.0% | 0.71% | – |
BTWN | New | BRIDGETOWN HOLDINGS LTD | $1,125,000 | – | 72,688 | +100.0% | 0.70% | – |
HMCOU | New | HUMANCO ACQUISITION CORPunit 12/08/2023 | $942,000 | – | 85,500 | +100.0% | 0.59% | – |
FLACU | New | FRAZIER LIFESCIENCES ACQU COunit 12/09/2025 | $664,000 | – | 64,000 | +100.0% | 0.41% | – |
SCOAU | New | SCION TECH GROWTH Iunit 12/17/2025 | $604,000 | – | 58,500 | +100.0% | 0.38% | – |
PTMN | New | PORTMAN RIDGE FIN CORP | $571,000 | – | 299,088 | +100.0% | 0.36% | – |
CDLX | New | CARDLYTICS INC | $410,000 | – | 2,869 | +100.0% | 0.26% | – |
DIS | New | DISNEY WALT CO | $339,000 | – | 1,870 | +100.0% | 0.21% | – |
PYPL | New | PAYPAL HLDGS INC | $297,000 | – | 1,267 | +100.0% | 0.18% | – |
TDG | New | TRANSDIGM GROUP INC | $290,000 | – | 469 | +100.0% | 0.18% | – |
CVNA | New | CARVANA COcl a | $287,000 | – | 1,198 | +100.0% | 0.18% | – |
FICO | New | FAIR ISAAC CORP | $282,000 | – | 552 | +100.0% | 0.18% | – |
MA | New | MASTERCARD INCORPORATEDcl a | $281,000 | – | 787 | +100.0% | 0.18% | – |
V | New | VISA INC | $272,000 | – | 1,244 | +100.0% | 0.17% | – |
INTU | New | INTUIT | $270,000 | – | 710 | +100.0% | 0.17% | – |
NFLX | New | NETFLIX INC | $265,000 | – | 491 | +100.0% | 0.16% | – |
MDLZ | New | MONDELEZ INTL INCcl a | $255,000 | – | 4,360 | +100.0% | 0.16% | – |
MSFT | New | MICROSOFT CORP | $254,000 | – | 1,142 | +100.0% | 0.16% | – |
MCO | New | MOODYS CORP | $250,000 | – | 863 | +100.0% | 0.16% | – |
CHTR | New | CHARTER COMMUNICATIONS INC Ncl a | $251,000 | – | 379 | +100.0% | 0.16% | – |
GOOG | New | ALPHABET INCcap stk cl c | $246,000 | – | 140 | +100.0% | 0.15% | – |
CRM | New | SALESFORCE COM INC | $237,000 | – | 1,064 | +100.0% | 0.15% | – |
FB | New | FACEBOOK INCcl a | $235,000 | – | 860 | +100.0% | 0.15% | – |
AMT | New | AMERICAN TOWER CORP NEW | $231,000 | – | 1,027 | +100.0% | 0.14% | – |
SPGI | New | S&P GLOBAL INC | $230,000 | – | 700 | +100.0% | 0.14% | – |
WHR | New | WHIRLPOOL CORP | $227,000 | – | 1,259 | +100.0% | 0.14% | – |
HLXA | New | HELIX ACQUISITION CORP | $182,000 | – | 16,009 | +100.0% | 0.11% | – |
BTWNW | New | BRIDGETOWN HOLDINGS LTD*w exp 09/30/202 | $175,000 | – | 39,773 | +100.0% | 0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MOLECULAR TEMPLATES INC | 24 | Q2 2023 | 30.7% |
STRONGBRIDGE BIOPHARMA PLC | 22 | Q3 2021 | 73.1% |
GARRISON CAP INC | 18 | Q3 2020 | 9.9% |
BERKSHIRE HATHAWAY INC DEL | 17 | Q3 2019 | 5.8% |
EIGER BIOPHARMACEUTICALS INC | 17 | Q3 2022 | 1.7% |
AGILE THERAPEUTICS INC | 16 | Q1 2018 | 55.5% |
KALA PHARNACEUTICALS INC | 16 | Q4 2021 | 17.6% |
CM FIN INC | 16 | Q1 2019 | 7.8% |
SYNTA PHARMACEUTICALS CORP | 15 | Q2 2016 | 99.9% |
CTI BIOPHARMA CORP | 14 | Q4 2021 | 8.7% |
View CAXTON CORP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Addex Therapeutics Ltd. | February 14, 2023 | 718,849 | 0.9% |
Cardiff Oncology, Inc. | February 14, 2023 | 983,607 | 2.2% |
Rezolute, Inc. | February 14, 2023 | 1,860,518 | 5.0% |
Xeris Biopharma Holdings, Inc. | February 14, 2023 | 5,973,324 | 4.4% |
CTI BIOPHARMA CORP | February 14, 2022 | 2,239,300 | 2.3% |
Sierra Oncology, Inc. | February 14, 2022 | 1,119,322 | 7.0% |
Strongbridge Biopharma plcSold out | January 05, 2022 | 0 | 0.0% |
SUNESIS PHARMACEUTICALS INCSold out | February 16, 2021 | 0 | 0.0% |
Alcentra Capital Corp | February 14, 2020 | 1,005,000 | 7.8% |
Garrison Capital Inc. | February 14, 2020 | 1,223,096 | 7.6% |
View CAXTON CORP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
View CAXTON CORP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.